Original Research
Accepted on 04 Apr 2025
Immune Architecture in Stage III and IV Melanoma Identifies Distinct Patient Subgroups
Frontiers in Immunology
doi 10.3389/fimmu.2025.1560778
43,061 Publications
Volume 16 - 2025
Correction
Accepted on 04 Apr 2025
Corrigendum: Extracellular vesicles from human breast cancerresistant cells promote acquired drug resistance and proinflammatory macrophage response
Frontiers in Immunology
doi 10.3389/fimmu.2025.1595885
Review
Accepted on 04 Apr 2025
The mechanism of action and therapeutic potential of tumor-associated macrophages in tumor immune evasion
Frontiers in Immunology
doi 10.3389/fimmu.2025.1545928
Original Research
Accepted on 04 Apr 2025
Clinical Manifestations and Risk Factors of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1 Inhibitors: A Case-Control Study
Frontiers in Immunology
doi 10.3389/fimmu.2025.1581057
Original Research
Accepted on 04 Apr 2025
Quantifying treatment response to a macrophage-targeted therapy in combination with immune checkpoint inhibitors after exposure to conventional chemotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1565953
Original Research
Accepted on 04 Apr 2025
A predictive model for the transformation from cervical inflammation to cancer based on tumor immune-related factors
Frontiers in Immunology
doi 10.3389/fimmu.2025.1532048
Original Research
Accepted on 04 Apr 2025
Mimicking Immune Complexes for efficient Antibody Responses
Frontiers in Immunology
doi 10.3389/fimmu.2025.1570487
Original Research
Accepted on 04 Apr 2025
Genome-wide association study and transcriptomic analysis reveal the crucial role of sting1 in resistance to visceral white-nodules disease in Larimichthys polyactis
Frontiers in Immunology
doi 10.3389/fimmu.2025.1562307
Correction
Accepted on 04 Apr 2025
Corrigendum: Case Report: HLA-DRB1 04:01 found in a child with adenovirus type 2 -linked hepatitis
Frontiers in Immunology
doi 10.3389/fimmu.2025.1592744
Review
Accepted on 04 Apr 2025
Monoamine Signaling and Neuroinflammation: Mechanistic Connections and Implications for Neuropsychiatric Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1543730
Opinion
Accepted on 04 Apr 2025
Value of Animal Sepsis Research in Navigating the Translational Labyrinth
Frontiers in Immunology
doi 10.3389/fimmu.2025.1593342
Original Research
Accepted on 04 Apr 2025
FOXA2/miR-148a-3p/SMURF2 signaling feed-forward loop alleviates spinal cord ischemia-reperfusion injury-induced neuropathic pain by modulating microglia polarization in rats
Frontiers in Immunology
doi 10.3389/fimmu.2025.1563377
Original Research
Accepted on 04 Apr 2025
Mapping the genetic landscape of immune-mediated disorders: potential implications for classification and therapeutic strategies
Frontiers in Immunology
doi 10.3389/fimmu.2025.1543781
Original Research
Accepted on 04 Apr 2025
To Determine the Role of TRIT1 in the Diagnosis, Prognosis and Immunoinvasion of Liver Hepatocellular Carcinoma
Frontiers in Immunology
doi 10.3389/fimmu.2025.1563442
Original Research
Accepted on 04 Apr 2025
Different pathways responses involving Tfh cells delay parasite-specific antibody production in Trypanosoma cruzi acute experimental models
Frontiers in Immunology
doi 10.3389/fimmu.2025.1487317
Original Research
Published on 04 Apr 2025
Clinical potential and experimental validation of prognostic genes in hepatocellular carcinoma revealed by risk modeling utilizing single cell and transcriptome constructs
Frontiers in Immunology
doi 10.3389/fimmu.2025.1541252